Author

Martti A. Färkkilä

PSC: Management and treatment options
PSC: Management and treatment options

Martti A. Färkkilä

NOVEL PROGNOSTIC SCORES TO PREDICT DISEASE OUTCOMES IN PRIMARY SCLEROSING CHOLANGITIS (PSC)
NOVEL PROGNOSTIC SCORES TO PREDICT DISEASE OUTCOMES IN PRIMARY SCLEROSING CHOLANGITIS (PSC)

Martti A. Färkkilä

NOVEL PROGNOSTIC SCORES TO PREDICT DISEASE OUTCOMES IN PRIMARY SCLEROSING CHOLANGITIS (PSC)
NOVEL PROGNOSTIC SCORES TO PREDICT DISEASE OUTCOMES IN PRIMARY SCLEROSING CHOLANGITIS (PSC)

Martti A. Färkkilä  et al.

NOVEL PROGNOSTIC SCORES TO PREDICT DISEASE OUTCOMES IN PRIMARY SCLEROSING CHOLANGITIS (PSC)
NOVEL PROGNOSTIC SCORES TO PREDICT DISEASE OUTCOMES IN PRIMARY SCLEROSING CHOLANGITIS (PSC)

PROTOCOL LIVER BIOPSY AFTER LIVER TRANSPLANTATION – IMPACT ON GRAFT SURVIVAL
PROTOCOL LIVER BIOPSY AFTER LIVER TRANSPLANTATION – IMPACT ON GRAFT SURVIVAL

Martti A. Färkkilä  et al.

NON-EROSIVE GASTROESOPHAGEAL REFLUX DISEASE AND RISK OF ESOPHAGEAL ADENOCARCINOMA
NON-EROSIVE GASTROESOPHAGEAL REFLUX DISEASE AND RISK OF ESOPHAGEAL ADENOCARCINOMA

Martti A. Färkkilä  et al.

Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline
Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline

Martti A. Färkkilä  et al.

DOMINANT STRICTURE IN PRIMARY SCLEROSING CHOLANGITIS: COMPARISON BETWEEN THE OLD AND NEW DEFINITION
DOMINANT STRICTURE IN PRIMARY SCLEROSING CHOLANGITIS: COMPARISON BETWEEN THE OLD AND NEW DEFINITION

Martti A. Färkkilä  et al.

CAN DYSPLASIA SURVEILLANCE BE BETTER TARGETED BY USING FAECAL CALPROTECTIN MEASUREMENTS IN ULCERATIVE COLITIS?
CAN DYSPLASIA SURVEILLANCE BE BETTER TARGETED BY USING FAECAL CALPROTECTIN MEASUREMENTS IN ULCERATIVE COLITIS?

Martti A. Färkkilä  et al.

Item 1 - 9 / 9
1